Pharma

Pharma

From new drug candidates and predictive cell culture models to development and manufacturing of innovative (bio-)pharmaceuticals to nanobiomedical applications.

Delimit selection

49 Results
  • Gene Therapy - Ready for the Market?

    Manufacturing, vectors, applications & regulatory aspects

  • Advances in Chemical Biology

    The upcoming Advances in Chemical Biology conference will feature latest research from all hot topics in chemical biology. Lectures by young researchers and...

  • 3rd European Conference on Natural Products

    In September 2018, the 3rd European Conference on Natural Products will again feature recent advances in secondary metabolite research. With a special...

  • 3D Cell Culture 2018

    How close to in vivo can we get? Get updated about 3D cell cultures as predictive, physiological relevant model systems! Since our first symposium in...

  • Status Paper "Facility of the Future"

    The biopharmaceutical industry has developed rapidly in recent decades, with biotechnologically manufactured drugs are at the top both in new approvals and new fields of application. Various trends such as the production of biosimilars have led to a real boom in new production facilities in recent years.
    Pharmaceutical companies are increasingly planning and constructing more flexible, smaller plants to meet the demand. These flexible Facilities of the Future (FoF) often use single-use systems. The Status Paper of the DECHEMA working group “Single-use technology in biopharmaceutical manufacturing” is an introduction in the field.

  • Advances in Chemical Biology

    (former Status Seminar Chemical Biology )

  • DECHEMA visits Berlin-Buch: Trading in cells - Lab cultures, patients, and the promise of applications

    Colloquium on 18.10.2017 at Campus Berlin-Buch. The colloquium is organised by Berlin Partner for Business and Technology GmbH, Campus Berlin-Buch, and supported by DECHEMA e.V.

  • Webinar: Biomarker - Platform technology for identifying innovative signatures

    Speaker: Dr. Ronny Schmidt, Sciomics GmbH, Heidelberg/D Innovative biomarker signatures are a cornerstone of precision medicine especially in the immune...

  • 10. Bundesalgenstammtisch

    Rückblick auf den 10. Bundesalgenstammtisch in Merseburg Optimierung von Produktionsverfahren mit Mikroalgen Produktionskosten sind der...

  • Phytoextracts - Proposal towards a new comprehensive research focus

    In order to meet the growing demand for and exploit the potential of phytoextracts for food, pharmaceutical or agrochemical applications, a coordinated research approach with adequate public funding is mandatory. In its current position paper “Phytoextracts – Proposal towards a new and comprehensive research focus”, the ProcessNet sub-division “Phytoextracts – Products and processes” outlines the state of research and technology and gives recommendations for research targets and approaches

Recommend
Become a member